Autres langues Medistim ASA

Actions

MEDI

NO0010159684

Equipement et technologie médicale avancés

Marché Fermé - Oslo Bors 16:45:00 01/10/2026			Varia. 5j.	Varia. 1 janv.
253,00 ^NOK	0,00%		+1,61%	-2,32%

15/09	Odin Small Cap a progressé de 4,15 % en août - 16 positions ont dépassé les attentes	FW
24/08	Danske Bank relève l'objectif de cours de Medistim à 340 couronnes norvégiennes (320) et réitère son conseil à l'achat - BN	FW

Autres langues

21/09	Medistim ASA(OB:MEDI) added to S&P Global BMI Index
14/09	Notice of extraordinary General Meeting in Medistim ASA
02/09	Notification of transactions by persons discharging managerial responsibilities (PDMR) and persons closely associated with them (KRT-1500)
21/08	Medistim ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
21/08	First half and second quarter results and financials for 2026 for Medistim ASA
13/08	First half and second quarter results and financials for 2026 for Medistim ASA
12/05	Medistim : Major shareholder disclosure in Medistim ASA
07/05	Medistim ASA Reports Earnings Results for the First Quarter Ended March 31, 2026
07/05	Medistim : 2026 the presentation
07/05	Ex dividend NOK 8.00 today
07/05	First quarter financial results 2026 for Medistim ASA
06/05	Protocol from the General Meeting in Medistim ASA where a dividend of NOK 8.00 per share was decided
30/04	Dividend proposal for 2025 Medistim ASA - Key information - correction
28/04	First quarter results and financials for 2026 for Medistim ASA
28/04	Dividend proposal for 2025 Medistim ASA - Key information
17/04	CEO share program- Correction
17/04	Medistim : CEO share program
14/04	Notice of Annual General Meeting in Medistim ASA
14/04	Board approval of the 2025 Financial statements for Medistim ASA
31/03	Financial calendar
18/03	Medistim : Intertrade Shipping AS purchases Medistim shares
13/03	Intertrade Shipping AS purchases Medistim shares
27/02	Medistim ASA Reports Earnings Results for the Full Year Ended December 31, 2025
27/02	Medistim to propose dividend of NOK 8.00 per share
27/02	Fourth quarter results and preliminary financials for 2025 for Medistim ASA